Alveolus Bio

[C. Vivek Lal @CVivekLaL]

Had a great time talking to @Amyshahmd on her podcast Save Yourself with Dr.Amy Shah! We had an engaging conversation covering health and wellness & the science behind @resbiotic & @AlveolusBio.

Also discussed the importance of academic commercialization and translation of lab science into ‘products and drugs’ to make actual impact.

Full podcast here: https://t.co/g4ppxP1odA

[C. Vivek Lal @CVivekLaL]

Thrilled to share our team’s @NatureComms paper on the 1st inhaled live biotherapeutics for chronic lung disease! Years of hard work & bold thinking led us to engineer “air as medicine.” Proud to see this work moving forward at @AlveolusBio with phase 1b trials soon! @UABHeersink @UABNews @anupamuab @uabpeds @atscommunity @ATS_RCMB @UABInnovation

https://t.co/WsFj6d2Jxa

[C. Vivek Lal @CVivekLaL]

Was great attending @PASMeeting with our @uabpeds colleagues, catching up with academic friends and exploring Toronto with @ResBiotic team!

Thanks to all who attended our talks on tantalizing therapeutics for BPD this morning!

[C. Vivek Lal @CVivekLaL]

Thanks @dougnoll, @AuthorityMgzine and https://t.co/umDSsP25Ih for this interview! https://t.co/Os9BeaJgqm
@ResBiotic @AlveolusBio
@UABNews @uabmedicine @UABHeersink @UABInnovation

[C. Vivek Lal @CVivekLaL]

Pleased to be presenting @AlveolusBio’s resMIT technology at @atscommunity #RIS2023.

Ping me if you are in DC and want to learn more about our @nih_nhlbi @NHLBI_SBIR funded technologies. @UABHeersink @uabpeds @UABMHIBI @UABPulmonary @UABInnovation @UABMicrobiome

[Alveolus Bio @AlveolusBio]

@CVivekLaL @NHLBI_SBIR @nih_nhlbi @UABNews @UABMHIBI @uabmedicine @UABPulmonary @UABMicrobiome @UABInnovation @InnovateAlabama @uabpeds @atscommunity @COPDFoundation @mehtag_mit

[MTIG @MTIG_News]

A recent study led by @AlveolusBio Founder, Vivek Lai M.D. found that experimental microbial dysbiosis in a preclinical model induces a redox imbalance & lung damage in neonatal mice which can be ameliorated using a live biotherapeutic mixture of bacteria. https://t.co/eU0QUVwIm6

[C. Vivek Lal @CVivekLaL]

A live biotherapeutic product reduces lung damage in mouse model of chronic lung disease https://t.co/8jg5IcxhJt @UABMHIBI @UABPulmonary @uabpeds @UABLungHealth @UABMicrobiome @UABNews @UABInnovation #microbiome @KentWillisMD @AlveolusBio

[Alveolus Bio @AlveolusBio]

@UABMicrobiome @uabpeds @UABPulmonary @UABLungHealth @UABInnovation @UABMHIBI

[Alveolus Bio @AlveolusBio]

Our Founder & CEO @CVivekLaL discussing New Frontiers in Microbiome Therapeutics: Inhaled LBPs for Chronic Lung Disease, at Boston today. @MTIG_News @microbiome_news @MicrobiomePost @KR_Microbiome @UABNews #microbiome #lbp #lunghealth #respiratory @PRI_Microbiome

[Alveolus Bio @AlveolusBio]

We will be presenting a corporate overview at Biotech Showcase next Tuesday! With #JPM22 and @EBDgroup’s #BiotechShowcase going virtual this year, registrants can tune in live or find a recording in the event center after the show.

Details👉 https://t.co/5rjXnZaUIF